Study title:
A follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma.
Ikekubo K, Habuchi Y, Jeong S, Yamaguchi H, Saiki Y, Ito H, Hino M, Higa T.
Clin Nucl Med. 1986 Nov;11(11):777-80.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
ATC code: V09BA02 |
Document link:
|
Document date: 2014-11-27
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|